Prognostic factors and scores for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide: results from a randomized phase III trial

K. Jahnke,P. Martus, T. Rose,L. Fischer, R. Moehle, H. A. Klasen,M. Rauch,A. Roeth,B. Hertenstein, T. Fischer, T. Hundsberger, H. -G Mergenthaler, M. Leithaeuser,T. Birnbaum,U. Herrlinger,J. Schubert,J. Birkmann,M. Weller,E. Thiel,A. Korfel

ONKOLOGIE(2011)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要